Pulmonary tuberculosis increases the risk of pulmonary thromboembolism: a nationwide population-based cohort study

Wei-Sheng Chung; Cheng-Li Lin; Yung-Fu Chen; Wu-Huei Hsu; Chia-Hung Kao

doi:10.1160/th14-05-0443

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 2014; 112(06): 1325-1327
DOI: 10.1160/th14-05-0443

Letters to the Editor

Schattauer GmbH

Pulmonary tuberculosis increases the risk of pulmonary thromboembolism: a nationwide population-based cohort study

Wei-Sheng Chung

¹Department of Internal Medicine, Taichung Hospital, Ministry of Health and Welfare, Executive Yuan, Taichung, Taiwan

²Graduate Institute of Clinical Medical Science and School of Medicine, College of Medicine, China Medical University, Taichung, Taiwan

³Department of Healthcare Administration, Central Taiwan University of Science and Technology, Taichung, Taiwan

,

Cheng-Li Lin

⁴Management Office for Health Data, China Medical University Hospital, Taichung, Taiwan

,

Yung-Fu Chen

³Department of Healthcare Administration, Central Taiwan University of Science and Technology, Taichung, Taiwan

,

Wu-Huei Hsu

²Graduate Institute of Clinical Medical Science and School of Medicine, College of Medicine, China Medical University, Taichung, Taiwan

,

Chia-Hung Kao

²Graduate Institute of Clinical Medical Science and School of Medicine, College of Medicine, China Medical University, Taichung, Taiwan

⁵Department of Nuclear Medicine and PET Center, China Medical University Hospital, Taichung, Taiwan

› Author Affiliations

Abstract

Full Text

References

References
1 Alikhan R, Cohen AT, Combe S. et al. Risk factors for venous thromboembolism in hospitalized patients with acute medical illness: analysis of the MEDENOX Study. Arch Intern Med 2004; 164: 963-968.
2 Matta F, Yaekoub AY, Stein PD. Human immuno-deficiency virus infection and risk of venous thromboembolism. Am J Med Sci 2008; 336: 402-406.
3 Lozinguez O, Arnaud E, Belec L. et al. Demonstration of an association between Chlamydia pneumoniae infection and venous thromboembolic disease. Thromb Haemost 2000; 83: 887-891.
4 Clayton TC, Gaskin M, Meade TW. Recent respiratory infection and risk of venous thromboembolism: case-control study through a general practice database. Int J Epidemiol 2011; 40: 819-827.
5 Dentan C, Epaulard O, Seynaeve D, Genty C, Bosson JL. Active Tuberculosis and Venous Thromboembolism: Association According to International Classification of Diseases, Ninth Revision Hospital Discharge Diagnosis Codes. Clin Infect Dis 2014; 58: 495-501.
6 Frieden TR, Jaffe HW, Stephens JW, Cardo DM, Zaza S. Trends in tuberculosis--United States, 2012. MMWR Morb Mortal Wkly Rep 2013; 62: 201-205.
7 CDC. Taiwan Tuberculosis Control Report 2012. In. Taipei City:: Centers of Disease Control, Department of Health, R. O. C. (Taiwan);; 2012
8 Zakai NA, McClure LA. Racial differences in venous thromboembolism. J Thromb Haemost 2011; 09: 1877-1882.
9 Turken O, Kunter E, Sezer M. et al. Hemostatic changes in active pulmonary tuberculosis. Int J Tuberc Lung Dis 2002; 06: 927-932.
10 Esmon CT, Xu J, Lupu F. Innate immunity and coagulation. J Thromb Haemost 2011; 09 (Suppl. 01) 182-188.
11 Piazza G, Goldhaber SZ. Pulmonary embolism in heart failure. Circulation 2008; 118: 1598-1601.
12 Lee AY, Levine MN. Venous thromboembolism and cancer: risks and outcomes. Circulation 2003; 107: I17-21.
13 Lee CH, Lin LJ, Cheng CL. et al. Incidence and cumulative recurrence rates of venous thromboembolism in the Taiwanese population. J Thromb Haemost 2010; 08: 1515-1523.